#Japan #Okayama #Okayama University #BNCT #SUT

Okayama University and Thailand's SUT Sign Collaboration for Cancer Treatment

In a significant development in the field of medical research, Okayama University, based in Japan, has forged an international collaboration with Suranaree University of Technology (SUT) in Thailand. This partnership, aimed at promoting Boron Neutron Capture Therapy (BNCT), was formalized on September 24, 2025, during a signing ceremony held at the SUT campus.

The agreement focuses on advancing research in BNCT, an innovative cancer treatment modality that leverages neutron beams to target cancer cells while minimizing damage to surrounding healthy tissues. The signing ceremony saw participation from key figures, including SUT’s Deputy President, Poonsiri Jongkool, and Okayama University’s Professor Keiichi Naruse, the director of the Neutron Medical Research Center (NTRC), alongside Associate Professor Kazuyo Ikawa.

Throughout the ceremony, both institutions underscored the importance of collaboration in research and expressed a shared commitment to not only pooling their resources but also enhancing their capabilities for the benefit of society. This agreement marks a crucial step in establishing international cooperation in science and technology between Japan and Thailand, thus providing a positive impact on both nations' research landscapes and benefitting local communities.

The NTRC at Okayama University was established in April 2017 with the mission of combining top-notch knowledge and skills to innovate BNCT research and create new dimensions in neutron therapy. According to Professor Sato Nobuhito, Vice President and Director of the Interdisciplinary Education and Research Organization, this new agreement will broaden and solidify the pathways for research advancement. He emphasized that it would accelerate the discovery of exciting new research avenues that yield promising treatments awaited by patients worldwide.

The collaboration between these two institutions is expected to facilitate multidisciplinary research, integrating various strengths from both sides. It aims to leverage each university's unique assets, ultimately translating breakthroughs into tangible societal benefits that enhance cancer treatment.

As a part of this agreement, the NTRC is poised to contribute significantly to the global landscape of cancer research and therapy, positioning itself as a leading entity in developing and implementing advanced treatment methodologies.

Both parties are keen on maximizing their research potentials through this partnership, aiming to deliver impactful results that not only advance academic understanding but also provide real-world applications for cancer treatment that can benefit patients on a global scale.

The importance of ongoing research cooperation in BNCT is paramount, as it represents hope for many cancer patients facing challenging diagnoses. As the collaboration between Okayama University and SUT unfolds, both institutions will focus on fostering innovation that could redefine the landscape of cancer treatment.

In conclusion, the collaboration between Okayama University and Suranaree University of Technology is a significant milestone that enhances both institutions' capabilities and expands the horizon of cancer treatment research. The dedicated efforts in this domain are anticipated to yield rewarding outcomes for the medical community, patients, and society at large.

As this partnership develops, we can look forward to groundbreaking discoveries and advancements in the realm of cancer therapies. Okayama University remains committed to its role as a fundamental player in scientific research and technology within both local and international contexts, contributing to sustainable development goals and the betterment of human health.